<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02486679</url>
  </required_header>
  <id_info>
    <org_study_id>0095-15-WOMC</org_study_id>
    <nct_id>NCT02486679</nct_id>
  </id_info>
  <brief_title>A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction</brief_title>
  <official_title>Cervical Ripening at Term With Prostaglandin E2 Tablets Versus Foley Catheter: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial comparing labor induction with vaginal PGE2 tablets and foley
      catheter for cervical ripening.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to active labor</measure>
    <time_frame>Post labor- up to 24 hours</time_frame>
    <description>Hours from foley cather placement or first PGE2 tablet placment to active labor, defined as cervical dilitation &gt;4 cm and/or cervical effacement&gt;80%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delivery within 24 hours</measure>
    <time_frame>post-labor - up to 24 hours</time_frame>
    <description>Delivery within 24 hours from foley catheter /first PGE2 tablet palcement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cesarean section rate</measure>
    <time_frame>post labor - up to 24 hours</time_frame>
    <description>Delivery via cesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal complications</measure>
    <time_frame>participants will be followed for labor course and the duration of hospital stay, an expected average of 5 days</time_frame>
    <description>Documented complications during labor, including: excessive hemmorhage, infection (chorioamnionitis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal complications</measure>
    <time_frame>Neonates of participants will be followed for labor course and the duration of hospital stay, up to 1 month</time_frame>
    <description>Documented complications such as non-reassuring fetal heart rate, fetal pH, NICU admission, early neonatal sepsis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Labor, Induced</condition>
  <arm_group>
    <arm_group_label>PGE2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients allocated to vaginal PGE2 (Prostin) for cervical ripening</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foley catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients allocated to foley catheter placement for cervical ripening</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prostin (PGE2) tablets</intervention_name>
    <arm_group_label>PGE2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley catheter</intervention_name>
    <arm_group_label>Foley catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton term pregnancies (&gt;37 weeks), vertex presentation

          -  Intact membranes

          -  Low Bishop score (&lt;7)

          -  First, second or third delivery

          -  Medical indication for induction

          -  Viable fetus

        Exclusion Criteria:

          -  Contraindication for vaginal delivery, for PGE2 or foley catheter

          -  Gestational age&lt;37 weeks, premature rupture of membranes, fetal or uterine
             malformations, previous cesarean section, uncertain dating, unwilling to participate
             in trial
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hadas Ganer Herman, MD</last_name>
    <phone>972526206696</phone>
    <email>hadassganer@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Edith Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadas Ganer Herman, MD</last_name>
      <phone>972526206696</phone>
      <email>hadassganer@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2015</study_first_submitted>
  <study_first_submitted_qc>June 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wolfson Medical Center</investigator_affiliation>
    <investigator_full_name>Hadas Ganer Herman</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

